Karyopharm Therapeutics Inc. buy melinda
Start price
06.03.18
/
50%
€14.72
Target price
17.05.18
€17.05
Performance (%)
16.42%
End price
17.05.18
€17.14
Summary
This prediction ended on 17.05.18 with a price of €17.14. The BUY prediction by melinda finished with a performance of 16.42%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Karyopharm Therapeutics Inc. | -1.930% | -1.930% | -45.355% | -83.371% |
iShares Core DAX® | 1.665% | 1.692% | 18.093% | 15.353% |
iShares Nasdaq 100 | -0.475% | 1.483% | 27.860% | 36.314% |
iShares Nikkei 225® | 2.620% | 4.475% | 17.651% | 10.750% |
iShares S&P 500 | -0.091% | 1.099% | 24.873% | 36.740% |
Comments by melinda for this prediction
In the thread Karyopharm Therapeutics Inc. diskutieren
Biotechnologie und medizinische SecteurRecherche
$ 16.18
0,89 (+ 5,82%) Selinexor - BOSTON multiplem Myelom
Phase 3 2019 2019.12.31 Phase-3-Studie Einleitung annoncé 7. Juni 2017. Anmeldung wird im Jahr 2018 mit Daten aufgrund im Jahr 2019 abgeschlossen.
(Zielkurs erreicht)
Stopped prediction by melinda for Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.42
25.08.20
25.08.20
€15.00
04.11.21
04.11.21
-43.59%
05.11.21
05.11.21
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€14.60
01.03.20
01.03.20
€17.00
25.08.20
25.08.20
-14.93%
25.08.20
25.08.20
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€5.04
28.03.19
28.03.19
€8.12
03.07.19
03.07.19
62.79%
03.07.19
03.07.19
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.96
28.01.18
28.01.18
€12.45
08.02.18
08.02.18
13.66%
08.02.18
08.02.18
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€9.89
13.01.18
13.01.18
€10.10
25.01.18
25.01.18
2.55%
25.01.18
25.01.18
Karyopharm Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.36
07.03.17
07.03.17
€12.45
30.03.17
30.03.17
9.31%
30.03.17
30.03.17